See more : Teac Corporation (6803.T) Income Statement Analysis – Financial Results
Complete financial analysis of Nanalysis Scientific Corp. (NSCIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nanalysis Scientific Corp., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- ITHAX Acquisition Corp. (ITHXU) Income Statement Analysis – Financial Results
- ARIS INTERNATIONAL LTD. (ARISINT.BO) Income Statement Analysis – Financial Results
- Bhagiradha Chemicals & Industries Limited (BHAGCHEM.NS) Income Statement Analysis – Financial Results
- Risuntek Inc. (002981.SZ) Income Statement Analysis – Financial Results
- Foresight Solar & Technology VCT plc (FTSV.L) Income Statement Analysis – Financial Results
Nanalysis Scientific Corp. (NSCIF)
About Nanalysis Scientific Corp.
Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance (NMR) spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It operates through three segments: Nanalysis, RS2D, and Corporate. The company also offers software module packages; manufactures and sells cutting-edge electronics components for precision analytical instruments; and provides monitoring and supporting services for its NMR technologies. It sells its products directly, as well as through a network of distributors worldwide. The company is headquartered in Calgary, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.47M | 24.82M | 16.04M | 7.87M | 8.36M | 8.38M | 7.67M | 5.25M |
| Cost of Revenue | 24.50M | 13.68M | 5.80M | 2.71M | 2.30M | 2.98M | 2.77M | 2.15M |
| Gross Profit | 3.97M | 11.14M | 10.24M | 5.17M | 6.06M | 5.40M | 4.89M | 3.10M |
| Gross Profit Ratio | 13.95% | 44.88% | 63.83% | 65.62% | 72.45% | 64.41% | 63.83% | 59.12% |
| Research & Development | 679.00K | 1.47M | 643.00K | 476.00K | 270.00K | 166.00K | 0.00 | 0.00 |
| General & Administrative | 11.04M | 12.67M | 6.14M | 3.51M | 2.77M | 2.26M | 1.32M | 1.33M |
| Selling & Marketing | 1.35M | 2.36M | 2.14M | 3.24M | 2.45M | 2.52M | 1.96M | 1.57M |
| SG&A | 12.39M | 15.02M | 8.28M | 6.75M | 5.22M | 4.77M | 173.33K | 25.25K |
| Other Expenses | -9.10M | 4.56M | 2.51M | 1.68M | 775.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.97M | 21.05M | 11.43M | 8.91M | 5.99M | 5.11M | 173.33K | 25.25K |
| Cost & Expenses | 40.09M | 34.73M | 17.23M | 11.62M | 8.30M | 8.09M | 173.33K | 25.25K |
| Interest Income | 0.00 | 76.00K | 2.00K | 328.00K | 59.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 902.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.67M | 4.65M | 2.58M | 1.75M | 845.00K | 372.00K | 164.71K | 110.96K |
| EBITDA | -8.85M | -5.26M | 1.38M | -1.86M | 484.00K | 485.00K | 1.78M | 324.43K |
| EBITDA Ratio | -31.08% | -19.53% | 12.21% | -17.89% | 29.11% | 8.29% | -2.26% | -0.48% |
| Operating Income | -11.62M | -9.50M | -608.00K | -3.18M | 1.59M | 323.00K | -173.33K | -25.25K |
| Operating Income Ratio | -40.82% | -38.26% | -3.79% | -40.37% | 19.01% | 3.85% | -2.26% | -0.48% |
| Total Other Income/Expenses | -5.17M | -2.54M | -1.43M | -985.00K | -1.96M | -152.00K | -167.47K | -77.09K |
| Income Before Tax | -16.80M | -10.40M | -1.77M | -3.98M | -1.40M | 136.00K | -172.11K | -25.28K |
| Income Before Tax Ratio | -59.00% | -41.90% | -11.05% | -50.48% | -16.73% | 1.62% | -2.24% | -0.48% |
| Income Tax Expense | -11.00K | -484.00K | 581.00K | -297.00K | 261.00K | 62.00K | 210.00K | 143.00K |
| Net Income | -16.78M | -9.92M | -2.35M | -3.68M | -1.66M | 74.00K | -172.11K | -25.28K |
| Net Income Ratio | -58.96% | -39.95% | -14.67% | -46.71% | -19.85% | 0.88% | -2.24% | -0.48% |
| EPS | -0.17 | -0.11 | -0.03 | -0.06 | -0.03 | 0.00 | -0.17 | -0.03 |
| EPS Diluted | -0.17 | -0.11 | -0.03 | -0.06 | -0.03 | 0.00 | -0.17 | -0.03 |
| Weighted Avg Shares Out | 99.18M | 92.48M | 70.40M | 65.32M | 55.63M | 60.92M | 1.03M | 1.00M |
| Weighted Avg Shares Out (Dil) | 99.18M | 92.48M | 70.40M | 65.32M | 55.63M | 60.92M | 1.03M | 1.00M |
Nanalysis Scientific Corp. Provides Update on Security Services Business
Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11, 2024 CALGARY, AB , Jan. 30, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI...
Nanalysis Scientific Corp. Announces Grant of Restricted Share Units
CALGARY, AB , Jan. 3, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ( TSXV:NSCI , OTCQX:NSCIF, FRA:1N1 ) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 475,000 Restricted Share Units ("RSU"s) to its independent Directors, pursuant to...
Nanalysis Scientific Corp. (NSCIF) Q3 2023 Earnings Call Transcript
Nanalysis Scientific Corp. (OTCQX:NSCIF) Q3 2023 Results Conference Call November 30, 2023 8:30 AM ET Company Participants Matthew Selinger - IR Sean Krakiwsky - Founder and CEO Randall McRae - CFO Conference Call Participants Stefan Quenneville - Echelon Capital Markets...
Nanalysis Reports Third Quarter 2023 Results
CALGARY, AB , Nov. 29, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30,...
Nanalysis Announces Third Quarter 2023 Conference Call
Hosting Call at 5:00 pm ET on Wednesday, November 29th European Q&A Session on November 30th at 8:30am ET CALGARY, AB , Nov. 15, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines...
Nanalysis to Present at the Planet MicroCap Showcase: VANCOUVER 2023 on Wednesday, September 6, 2023 & 1x1 Meetings on Thursday, September 7, 2023
CALGARY, AB , Aug. 30, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that it will be presenting at the Planet...
Nanalysis Scientific Corp. (NSCIF) Q2 2023 Earnings Call Transcript
Nanalysis Scientific Corp. (OTCQX:NSCIF) Q2 2023 Earnings Conference Call August 24, 2023 5:00 PM ET Company Participants Matthew Selinger - IR Randall McRae - CFO Sean Krakiwsky - Founder & CEO Conference Call Participants Stefan Quenneville - Echelon Capital Markets...
Nanalysis Reports Second Quarter 2023 Results
CALGARY, AB , Aug. 24, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its second quarter results ending June 30, 2023....
Nanalysis Announces Second Quarter 2023 Conference Call
Hosting Call at 5:00 pm ET on Thursday, August 24th European Q&A Session on August 25th at 8:30am ET CALGARY, AB , Aug. 15, 2023 /PRNewswire/ -Nanalysis Scientific Corp. ("the Company"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines...
Nanalysis to Present at LD Micro Invitational XIII
Presentation on Tuesday, June 6th at 1:30 PM PT CALGARY, AB , May 31, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research...
Source: https://incomestatements.info
Category: Stock Reports